Targeted synthesis and biological activity of polypharmacophoric agents for the treatment of neurodegenerative diseases
- Autores: Sokolov V.B.1, Makhaeva G.F.1, Aksinenko A.Y.1, Grigoriev V.V.1, Shevtsova E.F.1, Bachurin S.O.1
- 
							Afiliações: 
							- Institute of Physiologically Active Compounds, Russian Academy of Sciences
 
- Edição: Volume 66, Nº 10 (2017)
- Páginas: 1821-1831
- Seção: Reviews
- URL: https://journal-vniispk.ru/1066-5285/article/view/241405
- DOI: https://doi.org/10.1007/s11172-017-1953-y
- ID: 241405
Citar
Resumo
Synthetic approaches to the design of new multitarget agents for the treatment of neurodegenerative diseases are surveyed. These approaches are based on the conjugation of the pharmacophoric indole, phenothiazine, and aminoadamantane moieties via 1-oxopropylene and 2-hydroxypropylene spacers using reactions of acrylate- and epoxide-containing pharmacophores with tetrahydro-γ-carbolines, cycloalkaneindoles, carbazoles, and aminoadamantanes. The review considers data on biological activity of the compounds assessed within a complex screening system. This system includes neurotransmitter targets associated with cognitive compensation, such as cholinesterases and glutamate receptors, mitochondria, the influence on which can provide neuroprotective effects, and microtubules, the stabilization of which leads to the improvement of axonal transport. The ability of the compounds to act as free-radical scavengers was evaluated. Types of polypharmacophoric compounds promising for further development are proposed.
Sobre autores
V. Sokolov
Institute of Physiologically Active Compounds, Russian Academy of Sciences
							Autor responsável pela correspondência
							Email: alaks@ipac.ac.ru
				                					                																			                												                	Rússia, 							1 Severnyi proezd, Chernogolovka, Moscow Region, 142432						
G. Makhaeva
Institute of Physiologically Active Compounds, Russian Academy of Sciences
														Email: alaks@ipac.ac.ru
				                					                																			                												                	Rússia, 							1 Severnyi proezd, Chernogolovka, Moscow Region, 142432						
A. Aksinenko
Institute of Physiologically Active Compounds, Russian Academy of Sciences
														Email: alaks@ipac.ac.ru
				                					                																			                												                	Rússia, 							1 Severnyi proezd, Chernogolovka, Moscow Region, 142432						
V. Grigoriev
Institute of Physiologically Active Compounds, Russian Academy of Sciences
														Email: alaks@ipac.ac.ru
				                					                																			                												                	Rússia, 							1 Severnyi proezd, Chernogolovka, Moscow Region, 142432						
E. Shevtsova
Institute of Physiologically Active Compounds, Russian Academy of Sciences
														Email: alaks@ipac.ac.ru
				                					                																			                												                	Rússia, 							1 Severnyi proezd, Chernogolovka, Moscow Region, 142432						
S. Bachurin
Institute of Physiologically Active Compounds, Russian Academy of Sciences
														Email: alaks@ipac.ac.ru
				                					                																			                												                	Rússia, 							1 Severnyi proezd, Chernogolovka, Moscow Region, 142432						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					